Open Orphan subsidiary signs €6m contract with European biotech company | Business Post

📆 2022-03-25 오후 9:30:00
📰 businessposthq

⏱ Reading Time:
15 sec. here
2 min. at publisher
📊 Quality Score:
News: 9%
Publisher: 71%

대한민국 뉴스 뉴스

대한민국 최근 뉴스,대한민국 헤드 라인

Open Orphan subsidiary signs €6m contract with European biotech company, lorcanallen.

Open Orphan, the Dublin-listed pharmaceutical services company run by Cathal Friel, has announced that its hVIVO subsidiary has signed a £5 million contract with a European biotechnology company.

Under the terms of the contract, the European biotech company will test its intravenous antiviral candidate using the Hvivo human challenge study model for respiratory syncytial virus , an illness which affects the respiratory tract of children and at-risk adults. In severe cases it can...

이 소식을 빠르게 읽을 수 있도록 요약했습니다. 뉴스에 관심이 있으시면 여기에서 전문을 읽으실 수 있습니다. 더 많은 것을 읽으십시오:

댓글 쓰기

대한민국 최근 뉴스, 대한민국 헤드 라인

Similar News:다른 뉴스 소스에서 수집한 이와 유사한 뉴스 기사를 읽을 수도 있습니다.

Former chief justice Clarke defends legal work for retired judges | Business PostFormer chief justice Clarke defends legal work for retired judges, sanzscript reports.
출처: businessposthq - 🏆 8. / 71 더 많은 것을 읽으십시오 »

Making It Work: How a business was born in the aftermath of a tragedy | Business PostA sudden family bereavement ended up being the catalyst for Gillian Rijke to found her own home accessories business Lily Pad
출처: businessposthq - 🏆 8. / 71 더 많은 것을 읽으십시오 »